Clinical Trial Update: Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the effects of pitavastatin on monocyte activity, endothelial dysfunction and HDL-C in subjects with metabolic syndrome; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Kowa Research Europe | Conditions: Metabolic Syndrome | Phase 1 | Status: COMPLETED